VIVUS to Present at Three Investor Conferences in March 2013

        Print
| Source: VIVUS, Inc.

MOUNTAIN VIEW, Calif., March 4, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at three investment conferences during the month of March 2013.

The conference presentation schedule is as follows:

Cowen and Company 33rd Annual Health Care Conference
March 5, 2013, 8:00am EST
Boston Marriott Copley Place
Boston, MA
 
Barclays Global Healthcare Conference
March 14, 2013, 9:00am EST
Loews Miami Beach Hotel
Miami Beach, FL
 
Roth 25th Annual Conference
March 19, 2013, 1:00pm PST
The Ritz Carlton Laguna Niguel
Dana Point, CA

A live webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.

About VIVUS

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2012, and periodic reports filed with the Securities and Exchange Commission.

VIVUS, Inc.
Timothy E. Morris
Chief Financial Officer


Financial Media Relations:
Joele Frank, Wilkinson Brimmer Katcher
Jennifer Beugelmans

(212) 895-8692

Investor Relations:
The Trout Group
Brian Korb

646-378-2923